MYC

MYC. It is a master regulator gene encoding a transcription factor that is a central node in controlling essential cellular processes such as cell cycle progression, apoptosis, metabolism, and ribosome biogenesis. First identified as the cellular homolog of the oncogene from the avian myelocytomatosis virus, its dysregulation is a hallmark of a vast array of human cancers. The MYC protein functions by forming a heterodimer with MAX to bind E-box sequences in DNA, thereby activating or repressing a wide network of target genes critical for growth and proliferation.

Structure and function

The MYC gene is located on the long arm of chromosome 8 at locus 24.21. It encodes a protein with several conserved domains, most notably a basic helix-loop-helix (bHLH) motif and a leucine zipper (LZ) domain, which are essential for dimerization with its partner MAX and subsequent DNA binding. This MYC-MAX complex recognizes a specific nucleotide sequence known as the E-box (CACGTG) in the promoters of target genes. Through this mechanism, MYC orchestrates the expression of thousands of genes involved in processes like cell growth, protein synthesis, and energy metabolism. Its function is tightly coupled to cellular signals from pathways such as the Wnt, Hedgehog, and MAPK/ERK pathway.

Role in cancer

Dysregulation of MYC is one of the most common drivers of oncogenesis across a wide spectrum of human malignancies. This can occur through various genetic mechanisms, including gene amplification, as famously seen in Burkitt's lymphoma where chromosomal translocation places MYC under the control of the immunoglobulin enhancer. Other mechanisms involve point mutations that stabilize the protein or disrupt its normal regulatory controls. Constitutive MYC activation promotes tumorigenesis by driving uncontrolled cell proliferation, inhibiting differentiation, and enhancing angiogenesis. Its role is prominent in cancers such as neuroblastoma, breast cancer, prostate cancer, and small cell lung carcinoma. The MYC oncogene is also implicated in maintaining cancer stem cell populations and fostering metastasis.

Regulation of MYC expression

The expression of the MYC gene is controlled by a complex, multi-layered network of signals and factors. Transcriptionally, it is regulated by numerous transcription factors including those in the AP-1 family and NF-κB. A major point of control is at the level of protein stability; the MYC protein has a very short half-life and is rapidly degraded by the ubiquitin-proteasome system, a process mediated by phosphorylation events that target it for recognition by the SCF ubiquitin ligase complex, specifically the F-box protein FBXW7. Key upstream signaling pathways that converge on MYC include the PI3K/AKT/mTOR pathway, which can enhance its translation, and the RAS pathway, which activates its transcription. Post-transcriptional regulation via microRNAs like the let-7 family also plays a critical role in dampening MYC levels.

MYC as a therapeutic target

Directly targeting the MYC protein has been historically challenging due to its intrinsically disordered structure and its central role in normal physiology. However, intense research efforts have pursued several strategic avenues. These include disrupting the MYC-MAX dimerization interface with small molecules or peptide inhibitors, interfering with its binding to co-activators like BET bromodomain proteins such as BRD4, and using antisense oligonucleotides to reduce its expression. Clinical trials have investigated agents like OTX015, a BET inhibitor, in diseases like acute myeloid leukemia. Alternative approaches focus on synthetic lethality, targeting vulnerabilities in MYC-driven cancers, such as dependencies on specific metabolic pathways or the DNA damage response machinery involving PARP inhibitors.

Evolution and homology

The MYC gene family is evolutionarily ancient, with homologs found across the animal kingdom and even in simpler eukaryotes. In vertebrates, the family includes related members such as MYCN and MYCL, which arose from gene duplication events and have specialized roles, particularly during embryonic development and in specific tissues. The c-Myc protein (the product of the MYC gene) shares high sequence conservation in its bHLH and LZ domains with its relatives and with homologs in model organisms like Drosophila melanogaster (dMyc) and Caenorhabditis elegans. This deep conservation underscores its fundamental role in coordinating growth and proliferation in response to nutrient and growth factor signals, a core function maintained from flies to humans.

Category:Genes on human chromosome 8 Category:Human genes Category:Oncogenes Category:Transcription factors